Insider Buying: Vicente Anido Jr Buys 28,000 Shares of Aerie Pharmaceuticals Stock (AERI)
Aerie Pharmaceuticals (NASDAQ:AERI) CEO Vicente Anido, Jr. bought 28,000 shares of Aerie Pharmaceuticals stock in a transaction dated Wednesday, October 30th. The stock was purchased at an average price of $10.00 per share, for a total transaction of $280,000.00. Following the purchase, the chief executive officer now directly owns 28,000 shares of the company’s stock, valued at approximately $280,000. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.
Aerie Pharmaceuticals (NASDAQ:AERI) remained flat at $10.50 during during mid-day trading trading on Friday. The stock had a trading volume of 35,669 shares. The stock has a 50-day moving average of $0. and a 200-day moving average of $0.. The company’s market cap is $10.7 million.
Aerie Pharmaceuticals, Inc is a United States-based company. The Company is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.